Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality
✍ Scribed by Werner Lesslauer; Hisahiro Tabuchi; Reiner Gentz; Manfred Brockhaus; Ernst Juergen Schlaeger; Georges Grau; Pierre Francois Piguet; Pascal Pointaire; Pierre Vassalli; Hunsruedi Loetscher
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 351 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat
## Abstract The secretion of matrix metalloproteinase (MMP‐9) is stimulated by the glucocorticoid‐induced tumor necrosis factor receptor (GITR), a new tumor necrosis factor receptor (TNFR) family, in murine macrophages via an activation of protein kinase C (PKC)δ and phospholipase D (PLD). Secretio